ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 648

Performance of an Online Self-Referral Questionnaire Compared to a Physician-Based Referral Approach to Identify Patients with a High Probability of Axial Spondyloarthritis: Results from the Optiref Study

Fabian Proft1, Laura Spiller1, Mikhail Protopopov1, Valeria Rios Rodriguez1, Burkhard Muche1, Judith Rademacher1, Susanne Lueders2, Anne-Katrin Weber1, Inge Spiller1, Joachim Sieper3,4 and Denis Poddubnyy3,4, 1Charité Universitätsmedizin Berlin, Berlin, Germany, 2Department of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany, 3German Rheumatism Research Centre, Berlin, Germany, 4Charité Universitätsmeidzin Berlin, Berlin, Germany

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: axial spondyloarthritis and online resources, Referrals

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster I: Imaging, Clinical Studies, and Treatment

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: The diagnostic delay in axial spondyloarthritis (axial SpA) has been reported to be 9 years and still remains unacceptably high. One of the major reasons for this delay is a late referral of patients with suspicion of axial SpA by primary care (PC) physicians, dealing with patients with chronic back pain (CBP). Physician-based referral programs have performed well in recognition of patients with high probability of axial SpA among CBP patients. However, there is still an unmet need for patients who do not receive a referral recommendation to a rheumatologist because of lack of awareness on the PC level. The objective of this study was to develop and evaluate an online self-referral tool for CBP patients with suspicion of axial SpA.

Methods: Patients with CBP were included in the Identification of the Optimal Referral Strategy for Early Diagnosis of Axial Spondyloarthritis (OptiRef) Study and assessed by a rheumatologist if they either

1) were referred by a physician using the Berlin referral tool (CBP>3 months and CBP onset<45 years of age + at least 1 of the following 3 parameters: inflammatory back pain (IBP), HLA-B27 positivity, sacroiliitis on imaging), or 2) completed an online self-referral and indicated the presence of CBP>3 months with onset<45 years of age + at least 1 additional SpA parameter. Rheumatologist then performed a structured assessment of SpA features and made the diagnosis of axial SpA/non-axial SpA.

Results: A total of 362 patients were included in the study on a 1:1 ratio either referred by a physician using the Berlin referral tool or via the online self-referral tool. A total of 71 patients (39.9%) in the physician-referral group and 35 patients (19.3%) in the self-referral group were finally diagnosed with axial SpA (p<0.001). Patients who were included via the online referral tool had a longer symptom duration, were more often females, less often HLA-B27 positive and had less often elevated CRP as compared to physician-referred patients (table 1a).

In patients diagnosed with axial SpA the patients referred by a physician were more often male (p=0.041), HLA-B27 positive (p<0.001) and showed more often advanced radiographic changes in the sacroiliac joints leading to the diagnosis of radiographic axial SpA (=ankylosing Spondylitis) (p=0.033). All other demographic and clinical characteristics did not differ between the two groups (table 1b).

Conclusion: The self-referral strategy resulted in the diagnosis of axSpA in 19% of the patients as compared to 40% with a referral done by a physician. However, the proportion of axSpA among self-referred patients was clearly higher than the expected 5% prevalence of axSpA in patients with CBP. The online self-referral tool can be used, therefore, in addition to a physician based referral program to improve the early diagnosis and to increase awareness of axSpA.


Disclosure: F. Proft, None; L. Spiller, None; M. Protopopov, None; V. Rios Rodriguez, None; B. Muche, None; J. Rademacher, None; S. Lueders, None; A. K. Weber, None; I. Spiller, None; J. Sieper, None; D. Poddubnyy, None.

To cite this abstract in AMA style:

Proft F, Spiller L, Protopopov M, Rios Rodriguez V, Muche B, Rademacher J, Lueders S, Weber AK, Spiller I, Sieper J, Poddubnyy D. Performance of an Online Self-Referral Questionnaire Compared to a Physician-Based Referral Approach to Identify Patients with a High Probability of Axial Spondyloarthritis: Results from the Optiref Study [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/performance-of-an-online-self-referral-questionnaire-compared-to-a-physician-based-referral-approach-to-identify-patients-with-a-high-probability-of-axial-spondyloarthritis-results-from-the-optiref-s/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/performance-of-an-online-self-referral-questionnaire-compared-to-a-physician-based-referral-approach-to-identify-patients-with-a-high-probability-of-axial-spondyloarthritis-results-from-the-optiref-s/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology